細胞株開発血清市場は、2019 年の 9 億 1,558 万米ドルから、2027 年までに 14 億 6,792 万米ドルに達すると予想されています。市場は、2020 年から 2027 年にかけて 6.1% の CAGR で成長すると推定されています。
再生医療には、臓器だけでなく組織を置換または治癒し、先天性欠陥を正常化する可能性があります。加齢に伴う特定の異常、病気、外傷は、組織や器官に損傷を与えます。過去 10 世紀にわたって、組織工学産業は目覚ましい発展を遂げ、現在では生体機能の維持、修復、置換、強化のための臨床療法の開発に焦点を当てた、より広範な再生医療分野に発展しました。 、細胞工学を使用して。細胞株の開発は、再生医療において重要かつ不変の部分です。このように、再生医療の進歩により、細胞株の開発に使用される血清の需要が増加しています。
細胞株は、医薬品の試験と開発、細胞の開発において重要な役割を果たしています。に基づいた治療、およびがん組織に関連する研究、その他の応用が含まれます。製薬会社で開発された新薬は、その可能性を確認するために分化した幹細胞で安全かつ効果的に試験されます。さらに、細胞ベースのモデルを使用した再生医療は、研究者による変性疾患や外傷の早期介入治療に役立つ可能性があります。したがって、再生医療の使用の急増により、細胞株開発血清市場が推進されています。
細胞株開発血清の有利な地域市場
< br />
市場に関する洞察
再生医療の採用の増加
再生医療には組織を置換または治癒する可能性があります、臓器と同様に、先天性欠陥を正常化します。加齢に伴う特定の異常、病気、外傷は、組織や器官に損傷を与えます。過去 10 世紀にわたって、組織工学産業は目覚ましい発展を遂げ、現在では生体機能の維持、修復、置換、強化のための臨床療法の開発に焦点を当てた、より広範な再生医療分野に発展しました。 、細胞工学を使用して。細胞株の開発は、再生医療において重要かつ不変の部分です。したがって、再生医療の進歩により、細胞株の開発に使用される血清の需要が増加しています。
細胞株は、医薬品の試験と開発、細胞ベースの治療法の開発、および関連する研究に役立ちます。他の用途の中でもとりわけ、癌組織への適用。製薬会社で開発された新薬は、その可能性を確認するために分化した幹細胞で安全かつ効果的に試験されます。さらに、細胞ベースのモデルを使用した再生医療は、研究者による変性疾患や外傷の早期介入治療に役立つ可能性があります。したがって、再生医療の使用の急増により、細胞株開発血清市場が推進されています。
タイプ インサイト
タイプに基づいて、細胞株開発血清市場は、ウシ胎児血清、成体ウシ血清、ブタ血清、ウマ血清、およびその他の動物血清に分類されます。 2019年には、ウシ胎児血清セグメントが市場で最大のシェアを占めました。このセグメントの成長は、血液検査、尿検査、およびさまざまな画像処理手順の増加によるものと考えられています。
種類別の世界の細胞株開発血清市場– 2019 年と 2027 年
エンド ユーザー インサイト
アプリケーションに基づいた世界的な細胞株開発血清市場は、組織工学および再生医療、毒性試験、研究、創薬、生物生産に分割されています。 2019年には、バイオプロダクション部門が市場で最大のシェアを占めました。一方、創薬セグメントは、予測期間中に市場で最も高い CAGR を記録すると予想されます。
戦略的洞察
製品の発売と承認これは、増大する消費者の需要に応えるために、企業が世界的な拠点と製品ポートフォリオを拡大するために一般的に採用する戦略です。細胞株開発血清市場のプレーヤーは、提携戦略を採用して世界中の顧客ベースを拡大し、ブランド名を世界的に維持することも可能になります。
細胞株開発血清市場 –種類別
- ウシ胎児血清
- 成体ウシ血清
- ブタ血清
- ウマ血清
- その他の動物血清
細胞株開発血清市場 –用途別
- 生物生産
- 創薬
- 組織工学および再生医療
- 毒性試験
- 学術研究
細胞株開発血清市場 –地理別
- 北アメリカ
- 米国
- カナダ
- メキシコ
< li>ヨーロッパ - フランス
- ドイツ
- イタリア
- イギリス
- スペイン
- 残りヨーロッパ
- アジア太平洋 (APAC)
- 中国
- インド
- 韓国
- 日本
- オーストラリア
- その他のアジア太平洋地域
- 中東およびその他の地域
- 南アフリカ
- サウジアラビア
- UAE
- 中東のその他の地域およびその他の地域アフリカ
- ブラジル
- アルゼンチン
- 南米のその他の地域
会社概要
- ロンザ
- サーモフィッシャーサイエンティフィック株式会社< /li>
- Sigma-Aldrich Corporation (Merck KGaA)
- (Cytiva) Danaher
- PAN Biotech
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- Bovogen Biologicals Pty Ltd
- WuXi AppTec
- American Type Culture Collection (ATCC) グループ
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The cell line is established cell culture, wherein the cells multiply in the apt growth medium and space for growth. Different cell lines are made from other cells. The cell line development market growth is mainly attributed to the serum is broadly important as a source of growth and adhesion factors, lipids, hormones, and minerals for cells' culture in basal media. Besides, the serum also regulates cell membrane permeability and serves as a carrier for lipids, enzymes, micronutrients, and trace elements into the cell.
Increasing Adoption of Regenerative Medicines s expected to propel the growth of the Cell Line Development Serum market. Moreover, rising R&D investments and collaborations among by pharmaceutical and biotechnology companies.
The price of Cell Line Development Serum treatment is $ 168.80 for for fetal bovine serum and HyClone Cosmic Calf Serum, New Zealand origin cost at $ 256.00 USD. However, the cost profoundly differs based upon the customization
The List of Companies - Cell Line Development Serum Market
- Lonza
- Thermo Fisher Scientific Inc.,
- Sigma-Aldrich Corporation (MERCK KGaA)
- Cytiva (Danaher)
- PAN Biotech
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- Bovogen Biologicals Pty Ltd.
- WuXi AppTec
- American Type Culture Collection (ATCC)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Nov 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)